Literature DB >> 10360808

Infection by different HIV-1 subtypes (B and C) results in a similar immune activation profile despite distinct immune backgrounds.

Z Weisman1, A Kalinkovich, G Borkow, M Stein, Z Greenberg, Z Bentwich.   

Abstract

We compared the immune activation profile of 46 HIV-negative and 75 HIV-positive Israelis infected with HIV-1 subtype B, with 85 HIV-negative and 102 HIV-positive Ethiopian immigrants to Israel, who were infected with HIV subtype C. The HIV-negative Ethiopians had exceedingly high blood levels of eosinophils, immunoglobulin E (IgE), and p75s tumor-necrosis factor receptors (p75sTNFR); secretion of interleukin-4 (IL-4) and IL-10 by peripheral blood mononuclear cells (PBMC); proportion of human leukocyte antigen (HLA)-DR+ cells within CD3+, CD4+, and CD8+ T-cell subsets; and proportion of CD45RO+ CD4+ cells; while having significantly lower secretion of interferon-gamma (IFN-gamma) by PBMC and percentage of CD45RA+ CD4+ and CD28+ CD8+ cells. HIV infection in both populations was associated with reduced IL-2, IL-4, IL-10, and IL-12 secretion, number of CD28+ and CD45RA+ CD8+ cells, and increased number of HLA-DR+-CD3+, CD4+, and CD8+ cells, and CD45RO+ CD8+ cells. Thus, infection with HIV-1 subtypes B and C of studied Israelis and Ethiopians, respectively, results in a similar immune activation profile at all stages of the infection when living in the same environment, despite the striking different immune profile observed in the HIV-negative Israeli and Ethiopian populations. Together with our previous observations, this indicates that HIV subtype is not a major determinant in the natural course of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10360808

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  11 in total

Review 1.  Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization.

Authors:  Barb Lohman-Payne; Jennifer Slyker; Sarah L Rowland-Jones
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

3.  HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels.

Authors:  Michael A Eller; Marc S Opollo; Michelle Liu; Andrew D Redd; Leigh Anne Eller; Cissy Kityo; Joshua Kayiwa; Oliver Laeyendecker; Maria J Wawer; Mark Milazzo; Noah Kiwanuka; Ronald H Gray; David Serwadda; Nelson K Sewankambo; Thomas C Quinn; Nelson L Michael; Fred Wabwire-Mangen; Johan K Sandberg; Merlin L Robb
Journal:  J Infect Dis       Date:  2014-11-17       Impact factor: 5.226

4.  Assessment of CD8 T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Côte d'Ivoire.

Authors:  P Ondoa; S Koblavi-Dème; M-Y Borget; M L Nolan; J N Nkengasong; L Kestens
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

Review 5.  Effect of treating co-infections on HIV-1 viral load: a systematic review.

Authors:  Kayvon Modjarrad; Sten H Vermund
Journal:  Lancet Infect Dis       Date:  2010-07       Impact factor: 25.071

Review 6.  Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.

Authors:  S D Lawn; S T Butera; T M Folks
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

7.  Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy.

Authors:  G Borkow; Q Leng; Z Weisman; M Stein; N Galai; A Kalinkovich; Z Bentwich
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

Review 8.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 9.  Infectious diseases among Ethiopian immigrants in Israel: a descriptive literature review.

Authors:  Yulia Treister-Goltzman; Ali Alhoashle; Roni Peleg
Journal:  Pathog Glob Health       Date:  2021-02-24       Impact factor: 2.894

10.  Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection.

Authors:  Prasanta K Dash; Nagadenahalli B Siddappa; Asokan Mangaiarkarasi; Aruna V Mahendarkar; Padmanabhan Roshan; Krishnamurthy Kumar Anand; Anita Mahadevan; Parthasarathy Satishchandra; Susarla K Shankar; Vinayaka R Prasad; Udaykumar Ranga
Journal:  Retrovirology       Date:  2008-03-07       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.